Literature DB >> 24997392

Endoplasmic reticulum stress plays a role in the advanced glycation end product-induced inflammatory response in endothelial cells.

Lili Wu1, Da Wang1, Yan Xiao1, Xiaoyan Zhou1, Liqun Wang1, Bo Chen1, Qiang Li1, Xiaohua Guo1, Qiaobing Huang2.   

Abstract

AIMS: Both advanced glycation end products (AGEs) and endoplasmic reticulum (ER) stress play important roles in the development of various diseases. This study aimed to clarify the consequence of AGE-induced ER stress and its underlying mechanisms in human umbilical venous endothelial cells (HUVECs). MAIN
METHODS: AGE-induced ER stress was assessed by the increased expression and activation of the ER stress marker proteins GRP78, IRE1α and JNK, which were detected using Western blot. NF-κB translocation was revealed using Western blot and immunofluorescent staining in IRE1α-knockdown HUVECs. The mechanism of AGE-induced ER stress was also explored by inhibiting the effect of reactive oxygen species (ROS) using NADPH oxidase 4 (Nox4) siRNA and the antioxidant reduced glutathione (GSH). The cellular ROS level was measured using flow cytometry. KEY
FINDINGS: AGEs time- and dose-dependently enhanced the expression of GRP78 and increased the phosphorylation of IRE1α and its downstream signal JNK in HUVECs. siRNA-induced IRE1α down-regulation suppressed AGE-induced NF-κB p65 nuclear translocation. Inhibiting the ROS production using Nox4 siRNA or antagonizing ROS using GSH reduced cellular ROS level and attenuated AGE-induced GRP78 expression and IRE1α and JNK activation. SIGNIFICANCE: This study confirms that AGE-induced ER stress in HUVECs focuses on the ER stress-enhanced inflammatory response through JNK and NF-κB activation. It further reveals the involvement of ROS in the AGE-induced ER stress mechanism.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced glycation end products; Endoplasmic reticulum stress; Nuclear factor -κB; Reactive oxygen species; c-Jun N-terminal kinase

Mesh:

Substances:

Year:  2014        PMID: 24997392     DOI: 10.1016/j.lfs.2014.06.020

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  The IRE1/JNK signaling pathway regulates inflammation cytokines and production of glomerular extracellular matrix in the acute kidney injury to chronic kidney disease transition.

Authors:  Yan Liang; Lingyun Qu; Zhenjie Liu; Lulu Liang; Yingzi Wang; Songxia Quan; Yulin Wang; Lin Tang
Journal:  Mol Biol Rep       Date:  2022-06-13       Impact factor: 2.742

2.  Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury.

Authors:  Aric F Logsdon; Brandon P Lucke-Wold; Linda Nguyen; Rae R Matsumoto; Ryan C Turner; Charles L Rosen; Jason D Huber
Journal:  Brain Res       Date:  2016-04-27       Impact factor: 3.252

3.  Ghrelin alleviates endoplasmic reticulum stress and inflammation-mediated reproductive dysfunction induced by stress.

Authors:  Yueying Wang; Longqiao Cao; Xiaoran Liu
Journal:  J Assist Reprod Genet       Date:  2019-10-24       Impact factor: 3.412

4.  Renin-angiotensin system activation accelerates atherosclerosis in experimental renal failure by promoting endoplasmic reticulum stress-related inflammation.

Authors:  Jia Yang; Xi Zhang; Xinyi Yu; Weixue Tang; Hua Gan
Journal:  Int J Mol Med       Date:  2017-01-12       Impact factor: 4.101

Review 5.  Endoplasmic Reticulum Stress and Unfolded Protein Response in Cartilage Pathophysiology; Contributing Factors to Apoptosis and Osteoarthritis.

Authors:  Alexandria Hughes; Alexandra E Oxford; Ken Tawara; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  Int J Mol Sci       Date:  2017-03-20       Impact factor: 5.923

6.  Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial Cells.

Authors:  Huimin Hu; Changyuan Wang; Yue Jin; Qiang Meng; Qi Liu; Zhihao Liu; Kexin Liu; Xiaoyu Liu; Huijun Sun
Journal:  Inflammation       Date:  2019-02       Impact factor: 4.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.